The bioconjugation and radiosynthesis of (89)Zr-DFO-labeled antibodies Journal Article


Authors: Zeglis, B. M.; Lewis, J. S.
Article Title: The bioconjugation and radiosynthesis of (89)Zr-DFO-labeled antibodies
Abstract: The exceptional affinity, specificity, and selectivity of antibodies make them extraordinarily attractive vectors for tumor-targeted PET radiopharmaceuticals. Due to their multi-day biological half-life, antibodies must be labeled with positron-emitting radionuclides with relatively long physical decay half-lives. Traditionally, the positron-emitting isotopes124I (t1/2 = 4.18 d),86Y (t1/2 = 14.7 hr), and64Cu (t1/2 = 12.7 hr) have been used to label antibodies for PET imaging. More recently, however, the field has witnessed a dramatic increase in the use of the positron-emitting radiometal89Zr in antibody-based PET imaging agents.89Zr is a nearly ideal radioisotope for PET imaging with immunoconjugates, as it possesses a physical half-life (t1/2 = 78.4 hr) that is compatible with the in vivo pharmacokinetics of antibodies and emits a relatively low energy positron that produces high resolution images. Furthermore, antibodies can be straightforwardly labeled with89Zr using the siderophore-derived chelator desferrioxamine (DFO). In this protocol, the prostate-specific membrane antigen targeting antibody J591 will be used as a model system to illustrate (1) the bioconjugation of the bifunctional chelator DFO-isothiocyanate to an antibody, (2) the radiosynthesis and purification of a89Zr-DFO-mAb radioimmunoconjugate, and (3) in vivo PET imaging with an 89Zr-DFO-mAb radioimmunoconjugate in a murine model of cancer. © JoVE 2006-2015. All Rights Reserved.
Keywords: positron emission tomography; chemistry; antibody; desferrioxamine; 89zr; immunoconjugates; bioconjugation; issue 96
Journal Title: Journal of Visualized Experiments
Issue: 96
ISSN: 1940-087X
Publisher: MYJoVE Corporation  
Date Published: 2015-02-12
Start Page: e52521
Language: English
DOI: 10.3791/52521
PROVIDER: scopus
PUBMED: 25741890
PMCID: PMC4354640
DOI/URL:
Notes: Export Date: 2 April 2015 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Brian Zeglis
    118 Zeglis
  2. Jason S Lewis
    456 Lewis